Xintian Pharmaceutical: Major shareholder reduces holdings by 2.3 million shares, triggering a 1% change in equity.

Xintian Pharmaceutical announced that from June 8 to July 31, 2026, its controlling shareholder, Xintian Zhiyao, reduced its holdings in the company by a total of 2.3 million shares through centralized bidding and bulk trading, accounting for 0.9422% of the company's total share capital and 0.9674% of the total share capital after excluding shares in the repurchase special account. After this reduction, its shareholding ratio decreased from 28.7860% to 27.8186%, and the equity change triggered a 1% threshold. Previously, its shareholding ratio had already been diluted passively due to the company selling repurchased shares.